Literature DB >> 19926516

Intricacies of BMP receptor assembly.

Joachim Nickel1, Walter Sebald, Jay C Groppe, Thomas D Mueller.   

Abstract

The TGF-beta superfamily exhibits a feature making it distinct from many other growth factor families in that the inadequate number of ligands and receptors premises a high degree of promiscuity in ligand-receptor interaction. This highlights the importance of even small differences in affinities and specificities between different binding partners to maintain the broad spectrum of their well defined biological functions. Despite the promiscuous interactions recent data reveal differences in receptor recruitment, architectures of these assemblies and specific modulation by a multitude of extracellular as well as membrane-associated factors. These modulatory mechanisms might possibly add specificity towards defined biological functions despite the overlapping usage of receptors by various ligands.

Mesh:

Substances:

Year:  2009        PMID: 19926516     DOI: 10.1016/j.cytogfr.2009.10.022

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  50 in total

1.  Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling.

Authors:  Keren E Shapira; Avner Gross; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

2.  Crystallization of BMP receptor type IA bound to the antibody Fab fragment AbD1556.

Authors:  Stefan Harth; Alexander Kotzsch; Walter Sebald; Thomas Dieter Mueller
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-29

3.  Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Malcolm Whitman; Vicki Rosen; Ali H Brivanlou; Jay C Groppe; Walter Sebald; Thomas Mueller
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

4.  Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Authors:  Jenna H Newman; David J Augeri; Rachel NeMoyer; Jyoti Malhotra; Elaine Langenfeld; Charles B Chesson; Natalie S Dobias; Michael J Lee; Saeed Tarabichi; Sachin R Jhawar; Praveen K Bommareddy; Sh'Rae Marshall; Evita T Sadimin; John E Kerrigan; Michael Goedken; Christine Minerowicz; Salma K Jabbour; Shengguo Li; Mary O Carayannopolous; Andrew Zloza; John Langenfeld
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

5.  TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.

Authors:  Tao Huang; Laurent David; Valentín Mendoza; Yong Yang; Maria Villarreal; Keya De; LuZhe Sun; Xiaohong Fang; Fernando López-Casillas; Jeffrey L Wrana; Andrew P Hinck
Journal:  EMBO J       Date:  2011-03-18       Impact factor: 11.598

6.  RGM co-receptors add complexity to BMP signaling.

Authors:  Thomas D Mueller
Journal:  Nat Struct Mol Biol       Date:  2015-06       Impact factor: 15.369

Review 7.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

Review 8.  TGF-β Superfamily Regulation of Follicle-Stimulating Hormone Synthesis by Gonadotrope Cells: Is There a Role for Bone Morphogenetic Proteins?

Authors:  Luisina Ongaro; Gauthier Schang; Catherine C Ho; Xiang Zhou; Daniel J Bernard
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

9.  Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization.

Authors:  Wan-Jong Kuo; Michelle A Digman; Arthur D Lander
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

10.  A selection fit mechanism in BMP receptor IA as a possible source for BMP ligand-receptor promiscuity.

Authors:  Stefan Harth; Alexander Kotzsch; Junli Hu; Walter Sebald; Thomas D Mueller
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.